Carl Zeiss Meditec AG header image

Carl Zeiss Meditec AG

AFX

Equity

ISIN DE0005313704 / Valor 1055489

Xetra (2026-09-03)

EUR 32.16-2.19%

Carl Zeiss Meditec AG
UMushroom community rating:

4.40 5 votes No rating yet

NegativeNeutralPositive

About company

Carl Zeiss Meditec AG, headquartered in Jena, Germany and listed on the Frankfurt Stock Exchange, is a medical-technology company focused principally on devices, software and consumables for eye care and microsurgery. Its product portfolio spans diagnostic imaging systems (including optical coherence tomography and retinal imaging), surgical platforms and visualization equipment (such as surgical microscopes and laser systems for refractive and cataract procedures), as well as intraocular lenses, disposables and clinical IT solutions that support workflow and data management. The company sells capital equipment to hospitals, eye clinics and private practices worldwide and generates recurring revenue from consumables, service contracts and software, while investing in research and regulatory approvals to maintain and extend its market position in ophthalmology and related microsurgical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-24.3%1Y

-64.9%3Y

-83.2%5Y

Performance

45.6%1Y

45.1%3Y

42.1%5Y

Volatility

3273 M

Market cap (USD)

172,123

Daily traded volume (Shares)

47.3 / 46.28

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.40

5 votes

Performance:

4.20

Innovation:

4.80

Society:

4.40

Nature:

4.20

Luba Schoenig

Switzerland, 08 Jun 2023

Highly innovative company who is expected to be one of the key riders on the virtual reality glasses wave

Tonia Zimmermann

Switzerland, 06 Jun 2023

Big potential ahead of them given the use of their solutions in apple products

Laura Bischofberger

Switzerland, 06 Jun 2023

Interessante Performance über die letzten Jahre. & mit der Vorstellung vom neuen Produkt gestern durch Apple, ist ein gross Auftrag garantiert

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

2.09%CHF 356.50

BACHEM HOLDING LTD

BACHEM HOLDING LTD Valor: 117649372

Annual Return

-50%0%+50%

Risk level

110

2.28%CHF 78.50

Straumann Holding Ltd

Straumann Holding Ltd Valor: 117544866

Annual Return

-50%0%+50%

Risk level

110

-1.35%CHF 95.02

Ypsomed Holding AG

Ypsomed Holding AG Valor: 1939699

Annual Return

-50%0%+50%

Risk level

110

-1.02%CHF 406.80

Vijaya Diagnostic Centre Ltd.

Vijaya Diagnostic Centre Ltd. Valor: 113420241

Annual Return

-50%0%+50%

Risk level

110

1.71%INR 1,505.95

medmix Ltd

medmix Ltd Valor: 112967710

Annual Return

-50%0%+50%

Risk level

110

0.67%CHF 8.99

Basilea Pharmaceutica Ltd, Allschwil

Basilea Pharmaceutica Ltd, Allschwil Valor: 1143244

Annual Return

-50%0%+50%

Risk level

110

-0.15%CHF 65.60

IVF HARTMANN Holding AG

IVF HARTMANN Holding AG Valor: 18762425

Annual Return

-50%0%+50%

Risk level

110

-3.44%CHF 126.50

Newron Pharmaceuticals S.p.A.

Newron Pharmaceuticals S.p.A. Valor: 2791431

Annual Return

-50%0%+50%

Risk level

110

0.81%CHF 12.38

Addex Therapeutics Ltd

Addex Therapeutics Ltd Valor: 2985075

Annual Return

-50%0%+50%

Risk level

110

0.74%CHF 0.027

SIX

FactSet

Clearbit

Logos provided by Clearbit